SCHEMBL8324387

SCHEMBL8324387

C=C(N[C@@H](CCC(=O)OCc1ccccc1)c1nc2cc(Cl)ccc2[nH]1)c1cc(Cl)c(C(=O)N2CCCC2)cc1/N=C\N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.35
HDAC4 P56524 2/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC7 Q8WUI4 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC10 Q969S8 2/20 0.35
HDAC11 Q96DB2 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
HDAC9 Q9UKV0 2/20 0.35
HDAC5 Q9UQL6 2/20 0.35
AAK1 Q2M2I8 4/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.32
ALOX12 P18054 1/20 0.32
APOBEC3A P31941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8324737 0.84 ALDH1A1 (0.31) ALDH1A1LMNAMEN1ALOX12APOBEC3A
SCHEMBL8323491 0.83 CCKBR (0.33) ALDH1A1LMNAMEN1ALOX12APOBEC3A
SCHEMBL8317153 0.82 MEN1 (0.31) ALDH1A1MEN1ALOX12APOBEC3AKMT2A
SCHEMBL8325063 0.81 HRH4 (0.38) PRCPHRH4HRH3
SCHEMBL8324513 0.79
SCHEMBL5096681 0.79 MEN1 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2989994 0.79 MEN1 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2998638 0.78 OPRM1 (0.35) AAK1OPRM1OPRD1CTDSP1ALDH1A1
SCHEMBL2998637 0.78 OPRM1 (0.35) AAK1OPRM1OPRD1CTDSP1ALDH1A1
SCHEMBL8322942 0.76 HSP90AA1 (0.36) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058743-A1 NOVEL SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES AND USE THEREOF AS FACTOR XA INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-15 WO disclosed